Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of Secondary Bile Acids in Intestinal Inflammation
NCT03724175Phase 3Terminated
- Sponsor
- Stanford University
- Start
- Aug 2019
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ursodeoxycholic acid in pouchitis, sponsored by Stanford University. Primary endpoint: Proportion of subjects who achieve clinical response at 10 weeks. Started Aug 2019; status: terminated.
02
Drugs
ursodeoxycholic acid
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT03724175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03724175.